Auranofin synergizes with the PARP inhibitor olaparib to induce ROS-mediated cell death in mutant p53 cancers
Source
Antioxidants - ISSN 2076-3921-12:3 (2023) p. 1-24
Co-targeting the EGFR and PI3K/Akt pathway to overcome therapeutic resistance in head and neck squamous cell carcinoma : what about autophagy?
Source
Cancers - ISSN 2072-6694-14:24 (2022) p. 1-10
Optimization of the solvent and in vivo administration route of auranofin in a syngeneic non-small cell lung cancer and glioblastoma mouse model
Source
Pharmaceutics - ISSN 1999-4923-14:12 (2022) p. 1-18
Auranofin and cold atmospheric plasma synergize to trigger distinct cell death mechanisms and immunogenic responses in glioblastoma
Source
Cells - ISSN 2073-4409-10:11 (2021) p. 1-22
Targeting pancreatic ductal adenocarcinoma and glioblastoma with oxidative stress-mediated treatment strategies : focus on tumor cell death and modulation of the tumor microenvironment
Source
Antwerpen, Universiteit Antwerpen, 2021,167 p.